Developing and Testing Health Warning Labels on the ENDS Device
ConditionElectronic Cigarette Use
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-35
SponsorFlorida International University
About this trial
In this project, after systematically developing electronic nicotine delivery systems (ENDS) pictorial health warning labels (HWLs), a proven clinical lab model will be used to examine and test their effect when these are placed on the ENDS device on a variety of subjective (e.g. satisfaction, harm perception, nicotine dependence, intention to quit) and objective outcomes (e.g. plasma nicotine, puff topography) in young adults.
Eligibility criteria
Qualifiers
Generally healthy individuals (determined by physical examination).
Age of 21-35 years.
Is willing to provide informed consent.
Is willing to attend the lab as required by the study protocol.
Disqualifiers
Report smoking cigarettes regularly (> 5 cigarettes/month in the past year).
Report regular use of any other tobacco/nicotine product (e.g., e-cig, pipes, cigars) in the past year.
Women who are breast-feeding or test positive for pregnancy (by urinalysis at screening).
Individuals with self-reported history of chronic disease or psychiatric conditions.
Trial design
Treatments tested in this trial
- Preferred ENDS
- Preferred ENDS with HWL
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Florida International University
Lead sponsor
University of Miami
Collaborator
Source ClinicalTrials.gov